Advancing AML Care: A Targeted Approach
Advancing AML Care: A Targeted Approach is organized by Prime Education, LLC.
Release Date: February 28, 2023
Expiration Date: February 27, 2024
Description:
With new developments in targeted therapies, molecular testing has emerged as a central component informing guideline-recommended treatment decisions for patients with acute myeloid leukemia (AML). This dynamic video activity features expert discussion on challenges and barriers to using and interpreting molecular tests results identified through real-world data obtained from a recent quality improvement initiative in patients with AML.
Don't miss the opportunity to stay up-to-date on the latest clinical evidence in molecular testing and treatment selection as well as strategies for managing adverse events associated with targeted therapies to improve outcomes for your patients with AML.
Agenda:
• Guideline Recommendations for Molecular Testing in AML: Which Genes to Test for and How
• Matching Patient to Therapy: Interpretation of Molecular Testing Reports
• Clinical Efficacy and Safety Data on FDA Approved and Emerging Therapies for Specific Mutations
• Adverse Event Management: What to Watch for With Each Targeted Therapy and Expert Recommendations for Mitigation
Learning Objectives:
• Apply evidence-based guidelines and expert recommendations to the selection, implementation, and interpretation of molecular tests for AML
• Review recent clinical efficacy and safety data and apply to the management of targeted therapies in patients with AML
• Align clinical practice with expert recommendations for the management of adverse events associated with targeted therapies for AML
Additional details will be posted as soon as information is available.